Alpha-erythropoietin in the treatment and prevention of anemia in patients with chronic kidney disease

Authors

  • Ya.A. Dombrovskyi City clinical hospital №18, Kyiv
  • M.D. Ivanova National medical University named after O. O. Bogomolets

DOI:

https://doi.org/10.22141/2307-1257.0.1.07.2014.76549

Keywords:

alpha-erythropoietin, anemia, chronic kidney disease, current guidelines for anemia treatment

Abstract

The paper discusses current international recommendations on the diagnosis and treatment of anaemia in chronic kidney disease. Presents a detailed analysis of the alpha-erythropoietin, discussed the advantages and disadvantages of its application in clinical practice.

Downloads

Download data is not yet available.

References

Ермоленко В.М., Николаев А.Ю. Эритропоэтин: биологические свойства и применение в клинике // Тер. арх. — 1990. — 62(11). — 141-145.

Bauer С. Erythropoietin — from gene structure to therapeutic applications // J. Perinat. Med. — 1995. — 23. — 77-81.

Wu H., Lee S.H., Gao J. et al. Inactivation of erythropoietin leads to defects in cardiac morphogenesis // Development. — 1999. — 126. — 3597-3605.

Buemi M., Nostro L., Romeo A. From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine // Cardiovasc. Hematol. Agents Med. Chem. — 2006. — 4(4). — 299-311.

Anagnostou A., Liu Z., Steiner M. et al. Erythropoietin receptor mRNA expression in human endothelial cells // Proc. Natl. Acad. Sci. USA. — 1994. — 91. — 3974-3978.

Ohneda O., Yanai N., Obinata M. Erythropoietin as a mitogen for fetal liver stromal cells which support erythropoiesis // Exp. Cell Res. — 1993. — 208. — 327-331.

Ogilvie M., Yu X., Nicolas-Metral V. et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts // J. Biol. Chem. — 2000. — 275. — 39754-39761.

Eckardt K.-U., Hartmann W., Vetter U. et al. // Eur. J. Pediatr. — 1990. — 149. — 459-464.

Іванов Д.Д., Корж О.М. Нефрологія в практиці сімейного лікаря: Навчально-методичний посібник. — 2-ге вид., переробл. — Донецьк: Видавець Заславський О.Ю., 2012. — С. 121-128.

Клінічні практичні настанови KDIGO (2012) з анемії при ХХН // Почки. — 2013. — № 1. — С. 71-76.

Grimm C., Wenzel A., Acar N. et al. Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration // Adv. Exp. Med. Biol. — 2006. — 588. — 119-131.

Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis // BMJ. — 1990 Mar 3. — 300(6724). — 573-578.

Goldberg N., Lundin A.P., Delano et al. Changes in left ventricular size, wall thickness and function in anemic patients treated with recombinant human erythropoietin // Am. Heart J. — 1992. — 124. — 424-427.

Foley R.N., Parfrey P.S., Morgan J. et al. A randomized controlled trial of complete correction of anemia in hemodialysis patients with asymptomatic concentric LV hypertrophy or LV dilatation // J. Am. Soc. Nephrol. — 1998. — 9. — 208A.

Mancini D.M., Katz S.D., Lang C.C. et al. Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure // Circulation. — 2003. — 107. — 294.

Van der Meer P., Lipsic E., Henning R.H. et al. Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats With Heart Failure After Myocardial Infarction // J. Am. Coll. Cardiol. — 2005. — 46. — 125-133.

Sowade O., Gross J., Sowade B. et al. Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with erythropoietin beta // J. Lab. Clin. Med. — 1997. — 129. — 97-105.

Jelkmann W. Renal erythropoietin: properties and production // Rev. Physiol. Biochem. Pharmacol. — 1986. — 104. — 139-217

Pablo E. Pergola, Gary Gartenberg, Min Fu, Steven Sun, Marsha Wolfson, Peter Bowers. A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoеtin alfa in CKD patient with anemia // Clinical journal of the American Society of Nephrology. — 2010 Apr.

Дударь И.А., Гончар Ю.И. Эффективность и безопасность препарата Эпобиокрин при коррекции анемии у пациентов с ХПН V ст., которые находятся на заместительной гемодиализной терапии // Украинский журнал нефрологии и диализа. — 2013. — № 3 — С. 24-32.

Published

2022-02-14

How to Cite

Dombrovskyi, Y., & Ivanova, M. (2022). Alpha-erythropoietin in the treatment and prevention of anemia in patients with chronic kidney disease. KIDNEYS, (1.07), 65–68. https://doi.org/10.22141/2307-1257.0.1.07.2014.76549

Issue

Section

To Help the Practitioner